Hyris
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 George Yard Lowr Ground Florida, Londo...Phone Number
+44 2039361227Website
www.hyris.netRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Hyris
Hyris is a privately held, UK-based biotechnology company founded in 2014 by an entrepreneurial team with deep experience in biotechnology and electronics. The company offers its partners and clients disruptive technologies that enable genetic testing of biological samples in any setting, at any time, all available in real time on dedicated software platforms.Explore more
Hyris Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hyris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Hyris
Funding: Get notified immidiatlly once Hyris has new funding data
Hyris, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Hyris recently announced quarterly report
Check if Hyris has recently received funding, and reach out quickly before it becomes old news!
Check out if Hyris is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Hyris launches new products
Click to see if Hyris had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Hyris
Compare insights from companies similar to Hyris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hyris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hyris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hyris.
Hyris Tech Stack
A closer look at the technologies used by Hyris
Hyris News & Media
Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market
LONDON, Jan 15, 2024 - (ACN Newswire) - A new international biotech group was born from the integration of Hyris Ltd, an innovative biotech company renowned worldwide for its disruptive genetic testing platform, and Ulisse Biomed S.p.A., also known as UBM Group or “UBM” only, an Italian-based publicly traded biotech company appreciated for its innovative testing platforms. Hyris Ulisse Corporate Integration - A new benchmark in the biotech market As anticipated on December 4th, the integration bHyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Hyris
Sign Up For FreeTo access detailed company insights
Hyris is a privately held, UK-based biotechnology company founded in 2014 by an entrepreneurial team with deep experience in biotechnology and electronics. The company offers its partners and clients disruptive technologies that enable genetic testing of biological samples in any setting, at any time, all available in real time on dedicated softwar... Read More
